News

In this role, Dr Fox will assume responsibility for regulatory affairs, pharmacovigilance and medical affairs. Clinical operations will continue to report to the medical director, Brett Charlton. Dr

Alsobrook comes to Exagen in 2006 as the company’s director of genomic marker discovery, responsible for quality control and analysis of genomic data using both standard statistical approaches

A special protocol assessment is intended to secure agreement on the design, size and endpoints of clinical trials that are intended to form the primary basis of an

The blinded study, conducted at seven centers across the US, included 1,831 pigmented skin lesions from 1,383 patients, making this the largest prospective study ever conducted in melanoma

Under the agreement, the Sirion sales force will promote MacuTrition and the NutriDox convenience kit and provide sampling for the TheraTears line. Barry Butler, president and CEO of

In addition to her role as CEO, Ms Laub is a member of the board of directors of Policy Studies. Previously, Ms Laub was CEO-in-residence of MML Group

JLL Partners and PharmaNet had previously announced that they had reached a definitive merger agreement for PDGI Acquisition to acquire PharmaNet. JLL PharmaNet Holdings and PDGI Acquisition are

In addition, the parties have agreed to jointly seek dismissal with prejudice of all claims and counterclaims asserted in the ongoing litigation between the parties. Ligand and Rockefeller

Net loss in 2008 was $98.1 million, or $1.03 per share, compared with a net income of $281.7 million, or $2.87 per share, in 2007. For the fourth